Similar articles

• Comparison of the risk of adverse events between risperidone and haloperidol in delirium patients.

  Miyaji S, Yamamoto K, Hoshino S, Yamamoto H, Sakai Y, Miyaoka H. Miyaji S, et al. Psychiatry Clin Neurosci. 2007 Jun;61(3):275-82. doi: 10.1111/j.1440-1819.2007.01655.x. Psychiatry Clin Neurosci. 2007. PMID: 17472596
• Comparison of risperidone oral solution and intramuscular haloperidol with the latter shifting to oral therapy for the treatment of acute agitation in patients with schizophrenia.

  Fang M, Chen H, Li LH, Wu R, Li Y, Liu L, Ye M, Huang J, Zhu S, Wang G, Zhang Q, Zheng H, Zhang L, Wang B, Zhou J, Zhao JP. Fang M, et al. Int Clin Psychopharmacol. 2012 Mar;27(2):107-13. doi: 10.1097/YIC.0b013e32834fc431. Int Clin Psychopharmacol. 2012. PMID: 22233697 Clinical Trial.
• Chronic restlessness with antipsychotics.

  Bratti IM, Kane JM, Marder SR. Bratti IM, et al. Am J Psychiatry. 2007 Nov;164(11):1648-54. doi: 10.1176/appi.ajp.2007.07071150. Am J Psychiatry. 2007. PMID: 17974927 Review. No abstract available.
• Case of delirium complicated with pneumonia that improved with blonanserin administration.

  Andoh H, Kato K, Sato R, Akama F, Sakaguchi T, Matsumoto H. Andoh H, et al. Psychiatry Clin Neurosci. 2010 Oct;64(5):588-9. doi: 10.1111/j.1440-1819.2010.02124.x. Psychiatry Clin Neurosci. 2010. PMID: 20923437 No abstract available.
• Managing agitation in the critical care setting.

  Santos AB, Wohlreich MM, Pinosky ST. Santos AB, et al. J S C Med Assoc. 1992 Aug;88(8):386-91. J S C Med Assoc. 1992. PMID: 1518285 Review.